Skip to main content
  1. Home
  2. Emerging Tech
  3. News

A Japanese firm has started selling a tiny one-person smoking room for the office

Add as a preferred source on Google

Winter is unquestionably a nasty time of year for office workers who smoke. It’s never fun having to step outside into the freezing cold in order to satisfy that pesky nicotine craving, your fingers and face turning ever bluer with every wheezy puff.

Such hardship clearly hasn’t escaped the attention of Japanese engineering firm Ryonetsu, according to a report on Wednesday from the Sankei Shimbun. Having apparently spotted a gap in the market, it recently launched a “compact and attractive” one-person smoking room designed especially for the office. Need a ciggie? Why, just hop into your personal smoking space, close the door, and get puffing.

Recommended Videos

Considering Japanese employees’ reputation for long hours and hard work, the box is a winner on multiple fronts. For starters, there’s no space for an additional person, a thoughtful design feature that prevents time-wasting chit-chat with co-workers. Secondly, the room can be placed right beside your desk so you don’t have to use up valuable work minutes making your way to and from an outside smoking area. This also means that if your job ever gets particularly stressful, you’re only two steps away from a soothing smoke.

Thanks to the room’s (fairly) high-tech design, office-based smokers can make their personal ciggie space super-comfortable as it incorporates not only a deodorizing air freshener, but also a filter and air conditioner.

one-person-smoking-room
Image used with permission by copyright holder

And should you happen to die while inside it from a smoking-related illness, or possibly karoshi, then its coffin-like shape means one less expense for your next of kin. Brilliant.

However, the ingenious one-person smoking room doesn’t come cheap. With a 216,000 yen (about $2,100) price tag, this particular piece of office furniture is surely aimed at only the most dedicated of smokers.

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more